Literature DB >> 35420364

Candidalysin, a Virulence Factor of Candida albicans, Stimulates Mast Cells by Mediating Cross-Talk Between Signaling Pathways Activated by the Dectin-1 Receptor and MAPKs.

Pu Song1,2, Ge Peng1,3, Hainan Yue1,3, Takasuke Ogawa3, Shigaku Ikeda1,3, Ko Okumura1, Hideoki Ogawa1, François Niyonsaba4,5.   

Abstract

PURPOSE: Although mast cells (MCs) modulate the activity of effector cells during Candida albicans infection, their role in the pathogenesis of candidiasis remains unclear. Candidalysin, a C. albicans-derived peptide toxin, is a crucial factor in fungal infections. We aimed to investigate the effect of candidalysin on MC activation and the underlying molecular mechanism.
METHODS: Serum from candidalysin-immunized mice was used to measure candidalysin expression in patients infected with C. albicans. MC degranulation and migration were evaluated by β-hexosaminidase release assay and chemotaxis assay, respectively. EIA and ELISA were used to evaluate the production of eicosanoids and cytokines/chemokines, respectively. The production of nitric oxide (NO) was measured with a DAF-FM diacetate kit, while reactive oxygen species (ROS) production was analyzed by flow cytometry. MAPK activation was evaluated by Western blotting.
RESULTS: We detected high candidalysin expression in the lesions of patients infected with C. albicans, and the MC number was increased in these lesions. LL-37 colocalized with MCs in the lesions of candidiasis patients. Candidalysin-enhanced MC accumulation in mice and treating LAD2 and HMC-1 cells with candidalysin induced their degranulation, migration, and production of pro- and anti-inflammatory cytokines/chemokines, eicosanoids, ROS, NO, and LL-37. Interestingly, C. albicans strains lacking candidalysin failed to induce MC activation. Moreover, candidalysin increased dectin-1 expression, and the inhibition of dectin-1 decreased MC activation. Downstream dectin-1 signaling involved the MAPK pathways.
CONCLUSION: The finding that candidalysin causes cutaneous MC activation may improve our understanding of the role of MCs in the pathology of cutaneous C. albicans infection.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Candida albicans; Candidalysin; Candidiasis; Inflammation; Mast cell

Mesh:

Substances:

Year:  2022        PMID: 35420364     DOI: 10.1007/s10875-022-01267-9

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.542


  57 in total

1.  Mast cells kill Candida albicans in the extracellular environment but spare ingested fungi from death.

Authors:  Elisa Trevisan; Francesca Vita; Nevenka Medic; Maria Rosa Soranzo; Giuliano Zabucchi; Violetta Borelli
Journal:  Inflammation       Date:  2014-12       Impact factor: 4.092

2.  Recognition of Candida albicans by Dectin-1 induces mast cell activation.

Authors:  Alejandro Nieto-Patlán; Marcia Campillo-Navarro; Octavio Rodríguez-Cortés; Samira Muñoz-Cruz; Isabel Wong-Baeza; Sergio Estrada-Parra; Iris Estrada-García; Jeanet Serafín-López; Rommel Chacón-Salinas
Journal:  Immunobiology       Date:  2015-05-11       Impact factor: 3.144

Review 3.  Multidrug-Resistant Candida: Epidemiology, Molecular Mechanisms, and Treatment.

Authors:  Maiken Cavling Arendrup; Thomas F Patterson
Journal:  J Infect Dis       Date:  2017-08-15       Impact factor: 5.226

Review 4.  The current treatment landscape: candidiasis.

Authors:  Matteo Bassetti; Maddalena Peghin; Jean-Francois Timsit
Journal:  J Antimicrob Chemother       Date:  2016-11       Impact factor: 5.790

5.  Mast cells phagocyte Candida albicans and produce nitric oxide by mechanisms involving TLR2 and Dectin-1.

Authors:  Karen Henriette Pinke; Heliton Gustavo de Lima; Fernando Queiroz Cunha; Vanessa Soares Lara
Journal:  Immunobiology       Date:  2015-09-07       Impact factor: 3.144

Review 6.  Skin Immunity to Candida albicans.

Authors:  Sakeen W Kashem; Daniel H Kaplan
Journal:  Trends Immunol       Date:  2016-05-10       Impact factor: 16.687

Review 7.  Epidemiology of candidemia and antifungal susceptibility in invasive Candida species in the Asia-Pacific region.

Authors:  He Wang; Ying-Chun Xu; Po-Ren Hsueh
Journal:  Future Microbiol       Date:  2016-10-18       Impact factor: 3.165

8.  Opportunistic pathogen Candida albicans elicits a temporal response in primary human mast cells.

Authors:  José Pedro Lopes; Marios Stylianou; Gunnar Nilsson; Constantin F Urban
Journal:  Sci Rep       Date:  2015-07-20       Impact factor: 4.379

9.  Processing of Candida albicans Ece1p Is Critical for Candidalysin Maturation and Fungal Virulence.

Authors:  Jonathan P Richardson; Selene Mogavero; David L Moyes; Mariana Blagojevic; Thomas Krüger; Akash H Verma; Bianca M Coleman; Jacinto De La Cruz Diaz; Daniela Schulz; Nicole O Ponde; Giulia Carrano; Olaf Kniemeyer; Duncan Wilson; Oliver Bader; Simona I Enoiu; Jemima Ho; Nessim Kichik; Sarah L Gaffen; Bernhard Hube; Julian R Naglik
Journal:  mBio       Date:  2018-01-23       Impact factor: 7.867

10.  Candidalysin is a fungal peptide toxin critical for mucosal infection.

Authors:  David L Moyes; Duncan Wilson; Jonathan P Richardson; Selene Mogavero; Shirley X Tang; Julia Wernecke; Sarah Höfs; Remi L Gratacap; Jon Robbins; Manohursingh Runglall; Celia Murciano; Mariana Blagojevic; Selvam Thavaraj; Toni M Förster; Betty Hebecker; Lydia Kasper; Gema Vizcay; Simona I Iancu; Nessim Kichik; Antje Häder; Oliver Kurzai; Ting Luo; Thomas Krüger; Olaf Kniemeyer; Ernesto Cota; Oliver Bader; Robert T Wheeler; Thomas Gutsmann; Bernhard Hube; Julian R Naglik
Journal:  Nature       Date:  2016-03-30       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.